Skip to main content
Mercury Laboratories Limited logo

Mercury Laboratories Limited — Investor Relations & Filings

Ticker · 538964 ISIN · INE947G01011 LEI · 98450068F40047C86C71 BSE.NS Manufacturing
Filings indexed 418 across all filing types
Latest filing 2023-09-28 Regulatory Filings
Country IN India
Listing BSE.NS 538964

About Mercury Laboratories Limited

https://mercurylabs.com/

Mercury Laboratories Limited specializes in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations. Established in 1962, the company focuses on therapeutic segments including gynecology, pediatrics, cardiology, and orthopedics. Its product portfolio encompasses various dosage forms such as tablets, capsules, liquid orals, and injectables. The company operates WHO-GMP certified manufacturing facilities, ensuring adherence to international quality standards. Mercury Laboratories maintains a significant presence in both domestic and international markets, providing healthcare solutions through a robust distribution network. Key products include specialized treatments for maternal health and pediatric care, alongside general medicine offerings.

Recent filings

Filing Released Lang Actions
Voting result and scrutinizer report of 42nd AGM of Mercury Laboratories Limited
Regulatory Filings
2023-09-28 English
Summary of Proceedings of 42nd AGM of Mercury Laboratories Limited_27.09.2023
Regulatory Filings
2023-09-27 English
Intimation regarding Closure of Trading Window
Regulatory Filings
2023-09-26 English
Details of Loss of Share Certificate_Mukesh Mandani
Regulatory Filings
2023-09-20 English
Details of loss of certificate_Jayaben shah
Regulatory Filings
2023-09-07 English
Revised 42nd Annual Report along with AGM notice for the FY 2022-23
Regulatory Filings
2023-09-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.